Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 22 sales; 759 institutions reported holding it in 13F filings for Q3 2026, worth $43.4B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
Holders of 5% or more of RVMD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Revolution Medicines, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Farallon Capital Partners, L.P. | 13G/A | 7.50%14.6M shares | −0.40 ppfrom 7.90% | Nov 9, 20236 filings | Feb 9, 2026 | SEC |
| FMR LLC | 13G/A | 7.20%15.4M shares | +2.20 ppfrom 5.00% | Feb 8, 20215 filings | Nov 5, 2026 | SEC |
| Farallon Capital Management, L.L.C. | 13G/A | 6.40%13.6M shares | – | Aug 13, 20261 filing | Aug 13, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.70%12.2M shares | +1.20 ppfrom 4.50% | Jul 17, 20252 filings | Jul 29, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.13%11.0M shares | New | Oct 30, 20261 filing | Oct 30, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
66 Schedule 13D and 13G filings on Revolution Medicines, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 20264:18 PM ET | Baker Bros. Advisors LPand 3 others | 13G/A | 4.92%10.6M shares | −0.38 ppfrom 5.30%Below 5% | Sep 30, 2026 | SEC |
| Nov 16, 202612:57 PM ET | Janus Henderson Group PLC | 13G/A | 3.50%7.57M shares | −1.60 ppfrom 5.10%Below 5% | Sep 30, 2026 | SEC |
| Nov 5, 20261:24 PM ET | FMR LLCand 1 other | 13G/A | 7.20%15.4M shares | +2.20 ppfrom 5.00% | Sep 30, 2026 | SEC |
| Oct 30, 202612:36 PM ET | Vanguard Capital Management LLC | 13G | 5.13%11.0M shares | New | Sep 30, 2026 | SEC |
| Aug 14, 20264:01 PM ET | Baker Bros. Advisors LPand 3 others | 13G | 5.30%11.4M shares | +0.40 ppfrom 4.90% | Jun 30, 2026 | SEC |
| Aug 13, 20265:20 PM ET | Farallon Capital Management, L.L.C.and 28 others | 13G/A | 6.40%13.6M shares | – | Jun 30, 2026 | SEC |
| Aug 13, 202612:31 PM ET | Janus Henderson Group PLC | 13G | 5.10%10.7M shares | +0.20 ppfrom 4.90% | Jun 30, 2026 | SEC |
| Jul 29, 20263:19 PM ET | BlackRock, Inc. | 13G | 5.70%12.2M shares | +1.20 ppfrom 4.50% | Jun 30, 2026 | SEC |
| May 15, 202611:23 AM ET | Janus Henderson Group PLC | 13G/A | 4.90%9.77M shares | −1.20 ppfrom 6.10%Below 5% | Mar 31, 2026 | SEC |
| Mar 27, 202611:38 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 17, 20264:19 PM ET | Baker Bros. Advisors LPand 3 others | 13G/A | 4.90%9.46M shares | −0.10 ppfrom 5.00%Below 5% | Dec 31, 2025 | SEC |
| Feb 10, 202611:19 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 3.60%6.99M shares | −1.90 ppfrom 5.50%Below 5% | Dec 31, 2025 | SEC |
| Feb 9, 20268:53 AM ET | Farallon Capital Partners, L.P.and 30 others | 13G/A | 7.50%14.6M shares | −0.40 ppfrom 7.90% | Dec 31, 2025 | SEC |
| Nov 14, 202512:39 PM ET | Janus Henderson Group PLC | 13G/A | 6.10%11.4M shares | +0.40 ppfrom 5.70% | Sep 30, 2025 | SEC |
| Nov 5, 202511:44 AM ET | FMR LLCand 1 other | 13G | 5.00%9.40M shares | – | Sep 30, 2025 | SEC |
| Aug 14, 20254:26 PM ET | Baker Bros. Advisors LPand 3 others | 13G | 5.00%9.36M shares | New | Jun 30, 2025 | SEC |
| Aug 14, 202511:42 AM ET | Janus Henderson Group PLC | 13G/A | 5.70%10.6M shares | +0.20 ppfrom 5.50% | Jun 30, 2025 | SEC |
| Aug 12, 202510:34 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 5.50%10.3M shares | – | Jun 30, 2025 | SEC |
| Jul 17, 20257:54 PM ET | BlackRock, Inc. | 13G/A | 4.50%8.40M shares | –Below 5% | Jun 30, 2025 | SEC |
| May 15, 20259:24 AM ET | Farallon Capital Partners, L.P.and 29 others | 13G/A | 7.90%13.3M shares | +1.00 ppfrom 6.90% | Dec 31, 2024 | SEC |
| May 15, 20259:23 AM ET | Farallon Capital Partners, L.P.and 28 others | 13G/A | 6.90%11.3M shares | +1.80 ppfrom 5.10% | Sep 30, 2024 | SEC |
| May 15, 20259:22 AM ET | Farallon Capital Partners, L.P.and 28 others | 13G | 5.10%8.38M shares | – | Apr 12, 2024 | SEC |
| May 14, 202512:29 PM ET | Janus Henderson Group PLC | 13G/A | 5.50%10.2M shares | +0.30 ppfrom 5.20% | Mar 31, 2025 | SEC |
| Feb 14, 202511:25 AM ET | Janus Henderson Group PLC | 13G | 5.20%9.48M shares | New | Dec 31, 2024 | SEC |
| Nov 8, 2024 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | BB Biotech AG | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2024 | Farallon Capital Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Column Group III, LP | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2024 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Jan 26, 202411:49 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Nov 9, 2023 | Farallon Capital Partners, L.P. | 13GOld format | – | New | – | SEC |
| Nov 9, 2023 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Jun 30, 2023 | Biotechnology Value Fund L P | 13GOld format | – | – | – | SEC |
| Jun 16, 2023 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | BB Biotech AG | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Third Rock Ventures III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Column Group III, LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 6, 2023 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Jan 31, 20231:58 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 23, 2023 | EcoR1 Capital, LLC | 13GOld format | – | – | – | SEC |
| Dec 9, 2022 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Sep 30, 2022 | BB Biotech AG | 13GOld format | – | New | – | SEC |
| Jun 27, 2022 | EcoR1 Capital, LLC | 13GOld format | – | New | – | SEC |
| May 10, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Third Rock Ventures III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Cormorant Asset Management, LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
178 notices from officers, directors and other affiliates planning to sell Revolution Medicines, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 20264:32 PM ET | Stephen KelseyOfficer | 108.6K | $18.7M | Nov 16, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 12, 20267:56 AM ET | Jack Lee AndersOfficer | 35.8K | $6.90M | Nov 11, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 29, 20264:24 PM ET | Alan SandlerOfficer | 6.31K | $1.27M | Sep 29, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 25, 20264:17 PM ET | Anthony ManciniOfficer | 9.36K | $1.87M | Sep 25, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 24, 20264:42 PM ET | Anthony ManciniOfficer | 587 | $112.0K | Sep 24, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 22, 20264:13 PM ET | Elizabeth AndersonDirector | 15.1K | $2.91M | Sep 22, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 18, 20264:18 PM ET | Anthony ManciniOfficer | 1.76K | $347.4K | Sep 18, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 15, 20266:11 PM ET | Sandler Alan BOfficer | 331 | $67.4K | Sep 15, 2026 | ETRADE Financial Corporation | SEC |
| Sep 15, 20266:10 PM ET | Mancini AnthonyOfficer | 2.38K | $484.4K | Sep 15, 2026 | ETRADE Financial Corporation | SEC |
| Sep 15, 20266:09 PM ET | Kelsey Stephen MichaelOfficer | 5.42K | $1.10M | Sep 15, 202610b5-1 | ETRADE Financial Corporation | SEC |
| Sep 15, 20266:08 PM ET | Horn Margaret AOfficer | 4.83K | $984.2K | Sep 15, 202610b5-1 | ETRADE Financial Corporation | SEC |
| Sep 15, 20266:07 PM ET | Goldsmith Mark AOfficer · Director | 13.6K | $2.77M | Sep 15, 202610b5-1 | ETRADE Financial Corporation | SEC |
| Sep 15, 20266:06 PM ET | Cislini JeffOfficer | 3.27K | $666.7K | Sep 15, 202610b5-1 | ETRADE Financial Corporation | SEC |
| Sep 15, 20266:05 PM ET | Anders JackOfficer | 3.94K | $802.7K | Sep 15, 202610b5-1 | ETRADE Financial Corporation | SEC |
| Sep 11, 20264:32 PM ET | Stephen KelseyOfficer | 92.5K | $18.8M | Sep 11, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 10, 20264:39 PM ET | Anthony ManciniOfficer | 15.4K | $3.21M | Sep 10, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 31, 20265:11 PM ET | Lorence H KimAffiliate | 73.1K | $15.2M | Aug 31, 202610b5-1 | J.P. Morgan Securities LLC | SEC |
| Aug 21, 20264:38 PM ET | The Jonathan Goldsmith Revocable TrustDirector · Officer | 3.00K | $635.2K | Aug 21, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 21, 20264:38 PM ET | The Rebecca Goldsmith Revocable TrustDirector · Officer | 3.00K | $635.2K | Aug 21, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 21, 20264:37 PM ET | Mark A GoldsmithDirector · Officer | 80.0K | $16.9M | Aug 21, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 21, 20264:33 PM ET | Jeffrey Todd CisliniOfficer | 75.9K | $16.1M | Aug 21, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 29, 20264:44 PM ET | Sushil PatelDirector | 5.58K | $1.02M | Jun 29, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 24, 20264:35 PM ET | Jack AndersOfficer | 20.0K | $3.39M | Jun 24, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 15, 20266:30 PM ET | Goldsmith Mark AOfficer · Director | 9.77K | $1.50M | Jun 15, 202610b5-1 | ETRADE Financial Corporation | SEC |
| Jun 15, 20266:23 PM ET | Cislini JeffOfficer | 1.66K | $254.8K | Jun 15, 202610b5-1 | ETRADE Financial Corporation | SEC |
Showing the latest 25. See the RVMD notices from the last 12 months